Research and Progress

KSAT: Brain thinning could predict dementia 5 to 10 years before symptoms, local study shows

January 30, 2024

Through a decade’s worth of findings, researchers at the Biggs Institute for Alzheimer’s and Neurodegenerative Diseases at UT Health San Antonio are discovering a connection between the thickness of brain tissue to dementia risks. Claudia Satizabal, PhD, associate professor at the Biggs Institute and lead researcher on this study, said duplicating this marker could be […]


$32 million NIA grant boosts long COVID cognition study of under-studied populations including South Texas Hispanics

December 14, 2023

COVID-19’s long-term effects on cognition in older adults will be studied for five years thanks to a $32 million federal grant awarded to The University of Texas Health Science Center at San Antonio (also called UT Health San Antonio). The National Institute on Aging (NIA) grant, with UT Health San Antonio as the coordinating center, […]


TPR: Science & Medicine: Using AI for brain health diagnoses

October 29, 2023

  Artificial intelligence may be somewhat unsettling, but it also has the potential to improve and even save lives, according to Mohamad Habes, PhD, assistant professor of radiology and director of the neuroimaging core at the Glenn Biggs Institute for Alzheimer’s and Neurodegenerative Diseases at UT Health Science Center San Antonio. To listen to the podcast or […]



CNN: Genetic predisposition toward higher blood pressure, cholesterol may be linked to Alzheimer’s risk, study finds

May 18, 2023

Sudha Seshadri, MD, director of the Biggs Institute for Alzheimer’s and Neurodegenerative Diseases, was interviewed by CNN on a research study showing certain forms of higher blood pressure and cholesterol with a genetic link could be related to an increased risk of developing Alzheimer’s disease. To read the full article, visit CNN.com.



UT Health San Antonio scientists tie obesity to Alzheimer’s-related genes

February 22, 2023

Obesity in midlife and in women most closely linked to dementia. In a new study, researchers from The University of Texas Health Science Center at San Antonio (UT Health San Antonio) link obesity with 21 Alzheimer’s disease-related genes, providing a potential mechanistic explanation for why Alzheimer’s is sometimes more frequent among adults who experienced obesity […]



US News: 21 Genes Could Link Midlife Obesity & Alzheimer’s Risk

February 22, 2023

US News and Report features the new research study findings of Claudia Satizabal, PhD, and Sudha Seshadri, MD, of the Glenn Biggs Institute for Alzheimer’s and Neurodegenerative Diseases at UT Health San Antonio. The study reviews the connection between obesity and Alzheimer’s disease-related genes. To read the article, visit USNews.com.



Texas Tribune: The Rio Grande Valley is at the epicenter of an Alzheimer’s spike among Latinos and is now the focus of new research efforts

February 4, 2023

Sudha Seshadri, MD, founding director of the Glenn Biggs Institute for Alzheimer’s and Neurodegenerative Diseases at UT Health San Antonio, speaks to the spike of Alzheimer’s disease in South Texas and how in partnership with the University of Texas Rio Grande Valley, the institute is looking at why there are so many cases in South […]



Alzheimer’s disease clinical trial seeks 21 area volunteers

January 30, 2023

Study will evaluate senolytics — drugs that clear defective ‘zombie’ cells A clinical trial conducted at UT Health San Antonio aims to “stomp” out Alzheimer’s disease. Clearing old, damaged “zombie” cells from the brain may be one way to do it. The study, called SToMP-AD (Senolytic Therapy to Modulate the Progression of Alzheimer’s Disease), seeks 21 San […]



UT Health San Antonio specialists to discuss latest treatments of movement disorders

January 26, 2023

Deep brain stimulation, continuous levodopa infusion among topics Four fellowship-trained movement disorders neurologists from UT Health San Antonio will give talks Friday (Jan. 27) at the Parkinson’s Foundation Tri-State Symposium. These physicians will discuss the newest developments in research and clinical trials of Parkinson’s disease and other disorders. The symposium, free and open to the […]


A new era in Alzheimer’s treatment: FDA approval on lecanemab

January 11, 2023

Statement from the Glenn Biggs Institute for Alzheimer’s and Neurodegenerative Diseases at UT Health San Antonio about a timely topic in the news: The U.S. Food and Drug Administration on Friday, Jan. 6, 2023, approved lecanemab, a drug that targets the basic pathophysiology of Alzheimer’s disease. The FDA action is an “accelerated approval” of the […]